Teva Reports Fourth Quarter and Full Year 2011 Results

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter and year ended December 31, 2011. Q4 2011 Highlights: Net revenues of $5.7 billion, compared to $4.4 billion in the fourth quarter of 2010, an increase of 28%. Non-GAAP net income and Non-GAAP EPS of $1.4 billion and $1.59 diluted earnings per share, an increase of 23% and 27%, respectively, compared to $1.1 billion and $1.25 diluted earnings per share in the fourth quarter of 20

Feed Date: 
February 15, 2012